FREMONT, Calif.--(BUSINESS WIRE)--Ceterix ® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced the issuance of U.S. Patent No.
Hypertension (HT) is the one of the most common causes of myocardial dysfunction. Although in the majority of hypertensive patients in stage 1 or 2 of the disease, global left ventricular (LV) ...
To the Editor: In their study of circumferential pulmonary-vein ablation in patients with chronic atrial fibrillation, Oral et al. (March 2 issue) 1 do not mention evaluation or discuss the potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results